Prothena Corporation plc announced the publication of Phase 2 clinical trial data for coramitug (formerly PRX004), a potential first-in-class amyloid depleter antibody, for the treatment of ATTR ...
This 10-Min Easy Daily Mobility Routine is designed specifically for adults over 40 to relieve stiffness in the hips and ...
MedPage Today on MSN
Evolocumab Reduced First CV Events in Patients Without Prior MI or Stroke
NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...
Circle reported financial results for the third quarter on Wednesday. The transcript from the earnings call has been provided below.
For years, plastic surgeons thought the proportions of a beautiful buttocks should follow the Fibonacci sequence. Now, people are looking for a more Kardashian shape.
Amgen today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved statistically significant and clinically meaningful reductions in ...
Risk stratification of patients with chest pain has traditionally focused on identifying obstructive coronary artery disease (CAD). Using this traditional approach, many symptomatic individuals are ...
Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia set to launch in November Tonmya is the ...
We're giving you the chance to win a massive £30,000 with our huge new game Heart's 30K Double Play. Here’s how it works – We'll give you the name of a feel good artist you need to listen out for on ...
About 30% of cholesterol produced by the body is due to one’s lifestyle, a cardiologist says. Cardiac Vascular Sentral Kuala Lumpur (CVSKL) consultant cardiologist Dr Suren Thuraisingham said the rest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback